EPFL Investor Day 2024

10 Dec 2024 | Lausanne, Switzerland

Emovo Care SA

Startup

emovocare.com/Lausanne, Switzerland
3 profile visits

About

Emovo Care develops a neural EMG interface (non-medical) and a robotic hand exoskeleton (medical device) for people with motor impairments, at home.

Our 1st product is a medical device exoskeleton to support hand impairments after stroke. Based on novel soft-robotics tech protected by 2 patents, the system is comfortable and simple to use, to support therapy both in clinical settings and at home.
The company operates an ISO-13485 compliant QMS, and already deployed several systems for clinical and academic research worldwide.

Our next development include a world-unique neural device controllable via non-invasive muscular signals.
Our long term vision is to develop devices that can do “therapy while living”: assist patients in their daily life to increase motivation, meaningfulness, and dose of motor therapy -ultimately allowing to achieve better clinical recovery and improve quality of life.

Social media

Sectors

Health/MedTechRobotics

Representatives

Luca Randazzo

CEO

Emovo Care SA

Marketplace (1)

  • Investment

    Emovo seed

    Emovo develops the world's only neural hand exoskeleton for motor-impaired users, at home. Raising seed round (CHF 1.2M, 60% closed).

    • See stage.
    • Healthcare
    • Electronics
    • Biotech and Pharma
    Author

    Luca Randazzo

    CEO at Emovo Care SA

    Lausanne, Switzerland